This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of tinea corporis

Authoring team

Diagnosis should be confirmed via samples of skin scale.

Patients should be advised on skin hygiene to avoid predisposing factors of infection e.g. – the skin should be dry and cool at all times, avoid sharing towels, clothes etc (1).

Treatment is usually with topical antifungal therapy such as imidazole creams e.g. clotrimazole cream twice daily for four weeks.

  • An alternative is 1% terbanifine cream applied once or twice daily for one week (2)
  • Treatment should be continued for 1-2 weeks after the lesions have clinically been resolved (3)

Antifungal /topical steroid combinations may lead to a more rapid reduction in inflammtory symptoms (4) . However these combinations have no overall benefit (1).

Extensive skin infections may require oral therapies.

  • Before treatment a positive microscopy or a positive culture of skin scrapings is recommended (2)
  • Oral treatment options include:
  • terbinafine

 

  • griseofulvin

 

  • itraconazole (3)

 

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.